Wellington Management Group LLP liquidated 99.8% of its Bio-Techne Corp. stake.
A 13F filing dated September 13, 2026, disclosed the divestment.
The firm sold 5,109,880 shares during the second quarter.
Wellington now holds 10,305 shares.
The remaining position carries a value of approximately $728,000.
Bio-Techne reported quarterly earnings on August 12.
The company met earnings per share estimates of $0.52.
Revenue reached $321.19 million, exceeding analyst expectations.
Institutional investors collectively own 98.95% of the company's stock.